JP6399558B2 - 軟骨細胞から多能性幹細胞を製造する方法 - Google Patents

軟骨細胞から多能性幹細胞を製造する方法 Download PDF

Info

Publication number
JP6399558B2
JP6399558B2 JP2015539924A JP2015539924A JP6399558B2 JP 6399558 B2 JP6399558 B2 JP 6399558B2 JP 2015539924 A JP2015539924 A JP 2015539924A JP 2015539924 A JP2015539924 A JP 2015539924A JP 6399558 B2 JP6399558 B2 JP 6399558B2
Authority
JP
Japan
Prior art keywords
cells
population
cartilage
pluripotent stem
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015539924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502401A5 (enExample
JP2016502401A (ja
Inventor
ディリーマ，ダリル，ディー．
オリー，ツァイウェイ
コールウェル，クリフォード，ダブリュ．
Original Assignee
スクリップス ヘルス
スクリップス ヘルス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スクリップス ヘルス, スクリップス ヘルス filed Critical スクリップス ヘルス
Publication of JP2016502401A publication Critical patent/JP2016502401A/ja
Publication of JP2016502401A5 publication Critical patent/JP2016502401A5/ja
Priority to JP2018111416A priority Critical patent/JP6898657B2/ja
Application granted granted Critical
Publication of JP6399558B2 publication Critical patent/JP6399558B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/602—Sox-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/603—Oct-3/4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/604—Klf-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/606—Transcription factors c-Myc
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Transplantation (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2015539924A 2012-10-29 2013-10-29 軟骨細胞から多能性幹細胞を製造する方法 Active JP6399558B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018111416A JP6898657B2 (ja) 2012-10-29 2018-06-11 軟骨細胞から多能性幹細胞を製造する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261719901P 2012-10-29 2012-10-29
US61/719,901 2012-10-29
PCT/US2013/067350 WO2014070797A1 (en) 2012-10-29 2013-10-29 Methods of producing pluripotent stem cells from chondrocytes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018111416A Division JP6898657B2 (ja) 2012-10-29 2018-06-11 軟骨細胞から多能性幹細胞を製造する方法

Publications (3)

Publication Number Publication Date
JP2016502401A JP2016502401A (ja) 2016-01-28
JP2016502401A5 JP2016502401A5 (enExample) 2016-11-10
JP6399558B2 true JP6399558B2 (ja) 2018-10-03

Family

ID=50628010

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015539924A Active JP6399558B2 (ja) 2012-10-29 2013-10-29 軟骨細胞から多能性幹細胞を製造する方法
JP2018111416A Active JP6898657B2 (ja) 2012-10-29 2018-06-11 軟骨細胞から多能性幹細胞を製造する方法
JP2021093070A Pending JP2021153591A (ja) 2012-10-29 2021-06-02 軟骨細胞から多能性幹細胞を製造する方法
JP2022196593A Pending JP2023068668A (ja) 2012-10-29 2022-12-08 軟骨細胞から多能性幹細胞を製造する方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018111416A Active JP6898657B2 (ja) 2012-10-29 2018-06-11 軟骨細胞から多能性幹細胞を製造する方法
JP2021093070A Pending JP2021153591A (ja) 2012-10-29 2021-06-02 軟骨細胞から多能性幹細胞を製造する方法
JP2022196593A Pending JP2023068668A (ja) 2012-10-29 2022-12-08 軟骨細胞から多能性幹細胞を製造する方法

Country Status (4)

Country Link
US (2) US9914911B2 (enExample)
EP (1) EP2912166B1 (enExample)
JP (4) JP6399558B2 (enExample)
WO (1) WO2014070797A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2900808B1 (en) 2012-09-28 2019-04-03 Scripps Health Methods of differentiating stem cells into chondrocytes
EP2912166B1 (en) 2012-10-29 2019-05-01 Scripps Health Methods of producing pluripotent stem cells from chondrocytes
US9974885B2 (en) 2012-10-29 2018-05-22 Scripps Health Methods of transplanting chondrocytes
US9668892B2 (en) 2013-03-11 2017-06-06 Endospan Ltd. Multi-component stent-graft system for aortic dissections
US10758574B2 (en) * 2016-04-28 2020-09-01 The Board Of Trustees Of The Leland Stanford Junior University Cartilage cells with a high regenerative potential and low immune response for use in cellular therapy
CN105833275B (zh) * 2016-04-28 2019-12-27 中国医学科学院血液病医院(中国医学科学院血液学研究所) 一种利用重编程效应治疗白血病的方法
CN106267363B (zh) * 2016-09-18 2019-06-14 辽宁聚高智造科技有限公司 一种人造骨
WO2020130147A1 (ja) 2018-12-21 2020-06-25 国立大学法人京都大学 ルブリシン局在軟骨様組織、その製造方法及びそれを含む関節軟骨損傷治療用組成物
WO2021100796A1 (ja) * 2019-11-20 2021-05-27 一丸ファルコス株式会社 軟骨を作製するための剤及び軟骨の作製方法
JP7774794B2 (ja) * 2021-06-17 2025-11-25 学校法人近畿大学 人工耳介および人工軟骨組織の骨格構造

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5645851A (en) 1994-02-28 1997-07-08 Moore; Eugene R. Product for alleviating the symptons of arthritis in mammals
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
GB9503492D0 (en) 1995-02-22 1995-04-12 Ed Geistlich S Hne A G F R Che Chemical product
US6025327A (en) 1997-08-08 2000-02-15 Biocell Technology, Llc Hydrolyzed collagen type II and use thereof
US6511958B1 (en) 1997-08-14 2003-01-28 Sulzer Biologics, Inc. Compositions for regeneration and repair of cartilage lesions
US20030026786A1 (en) 1999-06-04 2003-02-06 Mark F. Pittenger Chondrogenic differentiation of human mesenchymal stem cells
EP1254670A1 (en) 2001-05-03 2002-11-06 Stichting Katholieke Universiteit Type II collagen matrices for use in cartilage engineering
US6780841B2 (en) 2001-11-13 2004-08-24 Biocell Technology, Llc Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
CA2412012C (en) 2001-11-20 2011-08-02 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Resorbable extracellular matrix containing collagen i and collagen ii for reconstruction of cartilage
US6852331B2 (en) 2002-02-11 2005-02-08 Taipei Biotechnology Ltd., Inc. Fabrication of a cartilage implant
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
WO2006015209A2 (en) 2004-07-29 2006-02-09 Stem Cell Innovations, Inc. Differentiation of stem cells
CN101103101B (zh) 2004-09-24 2012-10-10 成血管细胞系统公司 增强间充质前体细胞（mpc）的增生和/或存活的方法
TR201900968T4 (tr) 2004-09-24 2019-02-21 Mesoblast Inc Multipotansiyel genleşmiş mezenkimal prekürsör hücre soyu (memp) ve bunların kullanımı.
US20060189840A1 (en) 2005-02-18 2006-08-24 Acorn Cardiovascular, Inc. Transmyocardial delivery of cardiac wall tension relief
ES2329636B2 (es) * 2006-02-17 2010-07-26 Universitat De Valencia, Estudi General (Participa Con El 70%) Uso del factor pedf para inducir la auto-renovacion de celulas madre.
FR2900155B1 (fr) 2006-04-21 2008-06-27 Diana Naturals Sa Hydrolisat de cartilage aviaire, procede d'obtention et utilisations
CN101721349B (zh) 2008-10-16 2011-07-20 常州百瑞吉生物医药有限公司 可注射原位交联水凝胶及其制备方法和用途
KR101091028B1 (ko) 2009-07-02 2011-12-09 아주대학교산학협력단 체내 주입형 하이드로젤 및 이의 생의학적 용도
JP5636174B2 (ja) 2009-07-10 2014-12-03 学校法人近畿大学 間葉系細胞または軟骨細胞の製法ならびに発癌性の抑制方法
MX389666B (es) * 2009-10-16 2025-03-19 Scripps Research Inst Induccion de celulas pluripotentes.
JP6263329B2 (ja) 2009-11-24 2018-01-17 ザ ユニバーシティ オブ コネチカット ヒト胚性および人工多能性幹細胞の分化
KR100990436B1 (ko) 2009-11-30 2010-10-29 동국대학교 산학협력단 중간엽 줄기세포를 ＤＫＫ-1 또는 ｓＦＲＰ-1을 이용하여 연골세포로 분화시키는 방법
EP2529009A4 (en) 2010-01-28 2013-11-13 Univ Queensland METHOD OF STEM CELL DIFFERENTIATION
CA2800498C (en) 2010-03-31 2021-11-16 The Scripps Research Institute Reprogramming cells
EP2556147B1 (en) 2010-04-08 2018-10-03 The University Court Of The University of Edinburgh Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof
CN101810855B (zh) 2010-05-20 2012-06-13 广州创尔生物技术有限公司 一种ⅱ型胶原关节软骨修复液及其制备方法
CA2843050A1 (en) 2010-07-26 2012-02-02 The University Of Manchester Targeted differentiation of stem cells
CN101934092A (zh) 2010-08-27 2011-01-05 中国人民解放军第三军医大学第一附属医院 用于软骨再生修复的注射型软骨仿生基质材料及使用方法
WO2012048093A2 (en) 2010-10-08 2012-04-12 Osiris Therapeutics, Inc. Enhanced msc preparations
KR101340458B1 (ko) 2010-11-02 2013-12-11 서울대학교산학협력단 하이드로겔을 포함하는 연골 이식용 조성물
US8663675B2 (en) 2010-11-18 2014-03-04 Jalaledin Ghanavi Injectable matrix having a polymer and a stem cell niche composed of cup-shaped nanoparticles containing growth factors or physiological agents for organ reconstruction
JP2014509517A (ja) 2011-03-18 2014-04-21 アンセルム（アンスチチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル） 軟骨細胞分化培地および細胞の軟骨細胞分化を誘導するための方法
EP2900808B1 (en) 2012-09-28 2019-04-03 Scripps Health Methods of differentiating stem cells into chondrocytes
EP2912166B1 (en) * 2012-10-29 2019-05-01 Scripps Health Methods of producing pluripotent stem cells from chondrocytes
US9974885B2 (en) 2012-10-29 2018-05-22 Scripps Health Methods of transplanting chondrocytes
JP6473686B2 (ja) * 2013-03-25 2019-02-20 公益財団法人神戸医療産業都市推進機構 細胞の選別方法

Also Published As

Publication number Publication date
JP6898657B2 (ja) 2021-07-07
US20150275181A1 (en) 2015-10-01
EP2912166A4 (en) 2016-06-01
JP2023068668A (ja) 2023-05-17
EP2912166B1 (en) 2019-05-01
WO2014070797A1 (en) 2014-05-08
JP2018183141A (ja) 2018-11-22
EP2912166A1 (en) 2015-09-02
US10385318B2 (en) 2019-08-20
JP2021153591A (ja) 2021-10-07
JP2016502401A (ja) 2016-01-28
US20180155694A1 (en) 2018-06-07
US9914911B2 (en) 2018-03-13

Similar Documents

Publication Publication Date Title
JP6898657B2 (ja) 軟骨細胞から多能性幹細胞を製造する方法
US11859210B2 (en) Methods of differentiating stem cells into chondrocytes
US10071185B2 (en) Compartmental extract compositions for tissue engineering
JP2024050597A (ja) 免疫改変された多能性細胞から分化させた細胞
US11471285B2 (en) Tissue grafts and methods of making and using the same
US20150064141A1 (en) Regenerative sera cells and mesenchymal stem cells
US9725697B2 (en) Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof
US20260041817A1 (en) Biodegradable tissue replacement implant and its use
US9974884B2 (en) Bone regeneration agent
Rana et al. Induced Pluripotent Stem Cells in Scaffold‐Based Tissue Engineering
HK40110173A (en) Biodegradable tissue replacement implant and its use
JP2025106639A (ja) 軟骨修復用細胞シートおよびその製造方法
Michaela et al. Osteogenic induction of human osteoprogenitor cells in poly-caprolactone based scaffolds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150810

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160914

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160914

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171121

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180509

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180611

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20180620

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180816

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180829

R150 Certificate of patent or registration of utility model

Ref document number: 6399558

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250